BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21325287)

  • 21. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
    Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
    Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Theranostic application of telomerase-specific oncolytic adenovirus for human cancer].
    Fujiwara T; Tanaka N
    Nihon Rinsho; 2007 Oct; 65(10):1913-22. PubMed ID: 17926546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telomerase activity in cell lines of pediatric soft tissue sarcomas.
    Kleideiter E; Schwab M; Friedrich U; Koscielniak E; Schafer BW; Klotz U
    Pediatr Res; 2003 Nov; 54(5):718-23. PubMed ID: 12904596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A simple detection system for adenovirus receptor expression using a telomerase-specific replication-competent adenovirus.
    Sasaki T; Tazawa H; Hasei J; Osaki S; Kunisada T; Yoshida A; Hashimoto Y; Yano S; Yoshida R; Kagawa S; Uno F; Urata Y; Ozaki T; Fujiwara T
    Gene Ther; 2013 Jan; 20(1):112-8. PubMed ID: 22241176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telomerase activity and human telomerase reverse transcriptase mRNA expression in soft tissue tumors: correlation with grade, histology, and proliferative activity.
    Yan P; Coindre JM; Benhattar J; Bosman FT; Guillou L
    Cancer Res; 1999 Jul; 59(13):3166-70. PubMed ID: 10397260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
    Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
    Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-regulated oncolytic adenovirus with improved safety for adenocarcinoma therapy.
    Wei N; Fan JK; Gu JF; He LF; Tang WH; Cao X; Liu XY
    Biochem Biophys Res Commun; 2009 Oct; 388(2):234-9. PubMed ID: 19653996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor effects of telomelysin in combination with paclitaxel or cisplatin on head and neck squamous cell carcinoma.
    Kondo N; Tsukuda M; Kimura M; Fujita K; Sakakibara A; Takahashi H; Ishiguro Y; Toth G; Matsuda H
    Oncol Rep; 2010 Feb; 23(2):355-63. PubMed ID: 20043095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity.
    Irving J; Wang Z; Powell S; O'Sullivan C; Mok M; Murphy B; Cardoza L; Lebkowski JS; Majumdar AS
    Cancer Gene Ther; 2004 Mar; 11(3):174-85. PubMed ID: 14726958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
    Hu ZB; Wu CT; Wang H; Zhang QW; Wang L; Wang RL; Lu ZZ; Wang LS
    Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumoral immune response by recruitment and expansion of dendritic cells in tumors infected with telomerase-dependent oncolytic viruses.
    Edukulla R; Woller N; Mundt B; Knocke S; Gürlevik E; Saborowski M; Malek N; Manns MP; Wirth T; Kühnel F; Kubicka S
    Cancer Res; 2009 Feb; 69(4):1448-58. PubMed ID: 19190348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of telomerase activity and telomere length in bone and soft tissue tumors.
    Terasaki T; Kyo S; Takakura M; Maida Y; Tsuchiya H; Tomita K; Inoue M
    Oncol Rep; 2004 Jun; 11(6):1307-11. PubMed ID: 15138570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visualization of intrathoracically disseminated solid tumors in mice with optical imaging by telomerase-specific amplification of a transferred green fluorescent protein gene.
    Umeoka T; Kawashima T; Kagawa S; Teraishi F; Taki M; Nishizaki M; Kyo S; Nagai K; Urata Y; Tanaka N; Fujiwara T
    Cancer Res; 2004 Sep; 64(17):6259-65. PubMed ID: 15342413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of the transcriptional regulatory sequences of human calponin promoter and their use in targeting a conditionally replicating herpes vector to malignant human soft tissue and bone tumors.
    Yamamura H; Hashio M; Noguchi M; Sugenoya Y; Osakada M; Hirano N; Sasaki Y; Yoden T; Awata N; Araki N; Tatsuta M; Miyatake SI; Takahashi K
    Cancer Res; 2001 May; 61(10):3969-77. PubMed ID: 11358814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting gene-virotherapy of cancer.
    Liu XY; Gu JF
    Cell Res; 2006 Jan; 16(1):25-30. PubMed ID: 16467873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncolytic virus therapy for pancreatic cancer using the adenovirus library displaying random peptides on the fiber knob.
    Nishimoto T; Yoshida K; Miura Y; Kobayashi A; Hara H; Ohnami S; Kurisu K; Yoshida T; Aoki K
    Gene Ther; 2009 May; 16(5):669-80. PubMed ID: 19225547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models.
    Wohlfahrt ME; Beard BC; Lieber A; Kiem HP
    Cancer Res; 2007 Sep; 67(18):8783-90. PubMed ID: 17875719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Telomerase-specific virotherapy in an animal model of human head and neck cancer.
    Nakajima O; Matsunaga A; Ichimaru D; Urata Y; Fujiwara T; Kawakami K
    Mol Cancer Ther; 2009 Jan; 8(1):171-7. PubMed ID: 19139126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma.
    Sonabend AM; Ulasov IV; Tyler MA; Rivera AA; Mathis JM; Lesniak MS
    Stem Cells; 2008 Mar; 26(3):831-41. PubMed ID: 18192232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced antitumor efficacy of telomerase-selective oncolytic adenoviral agent OBP-401 with docetaxel: preclinical evaluation of chemovirotherapy.
    Fujiwara T; Kagawa S; Kishimoto H; Endo Y; Hioki M; Ikeda Y; Sakai R; Urata Y; Tanaka N; Fujiwara T
    Int J Cancer; 2006 Jul; 119(2):432-40. PubMed ID: 16477640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.